瘤微环境重塑介导的顺序性药物输送增强了治疗效率
Yajun Xu1,2,3, Jianlin Lv1,2,3, Fuyao Liu4,5,6
1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
Advanced materials (Deerfield Beach, Fla.)
|March 6, 2024
概括
这项研究引入了一种用于向癌症免疫治疗的序列纳米载体系统. 它有效地向瘤输送类似收费受体7/8激活剂 (IMDQs),在小鼠模型中消除它们而不会复发.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 托尔类受体7/8激活剂 (IMDQs) 在癌症免疫疗法方面表现有前途.
- 系统的IMDQs的管理是局限于非目标毒性.
- 需要新的药物输送策略来提高IMDQ的疗效和安全性.
研究的目的:
- 开发一种使用纳米载体进行向癌症免疫治疗的顺序药物递送系统.
- 通过降低全身毒性来增强意达佐基诺林 (IMDQs) 的疗效.
- 调查这种策略在根除已建立的瘤方面的潜力.
主要方法:
- 设计了一个由两个模块组成的序列纳米载体系统:CA4-NPs用于瘤微环境重塑和apcitide-PLG-IMDQ-N3用于向免疫治疗.
- CA4-NP 作为血管破坏剂,诱导瘤缺氧和凝血.
- 阿普胺-PLG-IMDQ-N3针对瘤凝血,并在低氧条件下释放激活的IMDQ.
主要成果:
- 纳米载体系统成功地重塑了瘤微环境,增强了瘤对激活IMDQ的吸收 (22.66%ID/g).
- 顺序递送策略导致在小鼠模型中根除了4T1和CT26瘤 (≈500毫米3).
- 治疗增强了瘤特异性CD8+T细胞的原始和免疫记忆,防止瘤复发.
结论:
- 连续的纳米载体输送IMDQs提供了一个有希望的策略,以克服系统性毒性和增强抗瘤免疫力.
- 这种方法通过调节瘤微环境并激活特定的免疫反应,有效地准和根除已建立的瘤.
- 这些发现支持这种双纳米载体系统在开发更安全,更有效的癌症免疫疗法方面的潜力.
更多相关视频
16:18Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
11.6K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
